Please enable JavaScript to continue using this application.

Compare $ARTV vs $ZNTL | Chartloom

Compare

$ARTV vs $ZNTL

Artiva Biotherapeutics Inc · Zentalis Pharmaceuticals Inc

ARTV

Artiva Biotherapeutics Inc

ZNTL

Zentalis Pharmaceuticals Inc

Compare $ARTV vs $ZNTL

Comparing Artiva Biotherapeutics Inc and Zentalis Pharmaceuticals Inc

ARTVArtiva Biotherapeutics Inc

ZNTLZentalis Pharmaceuticals Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

ZNTLZentalis Pharmaceuticals Inc

Market cap

$188M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

92.7%

52W performance

61.0%

FCF yield

-68.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

ZNTL

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

ZNTL

Zentalis Pharmaceuticals Inc

Market Cap

ARTV$337M

ZNTL$188M

Enterprise Value

ARTV$36M

ZNTL$163M

Price

ARTV$6.94

ZNTL$2.64

P/E Ratio

ARTVN/A

ZNTLN/A

P/S Ratio

ARTV0.00x

ZNTL0.00x

EV/Sales

ARTV0.00x

ZNTL0.00x

EV/EBITDA

ARTV0.00x

ZNTL0.00x

P/B Ratio

ARTV0.96x

ZNTL1.70x

P/FCF Ratio

ARTVN/A

ZNTLN/A

EV/FCF

ARTV-0.46x

ZNTL-1.27x

PEG Ratio

ARTVN/A

ZNTLN/A

Forward P/E (NTM)

ARTVN/A

ZNTLN/A

Forward P/S (NTM)

ARTVN/A

ZNTLN/A

Revenue (TTM)

ARTV$0

ZNTL$0

Revenue Growth (YoY)

ARTVN/A

ZNTLN/A

Forward Rev Growth

ARTV404.4%

ZNTL447.5%

Gross Margin (TTM)

ARTV0.0%

ZNTL0.0%

Operating Margin (TTM)

ARTV0.0%

ZNTL0.0%

EBITDA Margin (TTM)

ARTV0.0%

ZNTL0.0%

Net Margin (TTM)

ARTV0.0%

ZNTL0.0%

FCF Margin (TTM)

ARTVN/A

ZNTLN/A

Net Income (TTM)

ARTV$-42M

ZNTL$-62M

FCF (TTM)

ARTV$-77M

ZNTL$-128M

EPS (TTM)

ARTV$0.00

ZNTL$0.00

ROE (TTM)

ARTV-6022.0%

ZNTL-5277.0%

ROA (TTM)

ARTV-5238.0%

ZNTL-4055.0%

ROIC (TTM)

ARTV-6019.0%

ZNTL-5277.0%

Cash

ARTV$301M

ZNTL$25M

Debt

ARTV$0

ZNTL$0

Net Cash/Debt

ARTV$301M

ZNTL$25M

Current Ratio (TTM)

ARTV24.16x

ZNTL4.82x

Quick Ratio (TTM)

ARTV23.97x

ZNTL4.64x

Debt/Equity (TTM)

ARTV0.00x

ZNTL0.00x

Debt/Assets (TTM)

ARTV0.0%

ZNTL0.0%

Interest Coverage (TTM)

ARTVN/A

ZNTLN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

ZNTL0.00x

Beta

ARTV5.80

ZNTL1.92

52W Performance

ARTV131.3%

ZNTL61.0%

YTD Performance

ARTV64.1%

ZNTL92.7%

% from 52W High

ARTV-52.2%

ZNTL-62.0%

% from 52W Low

ARTV156.1%

ZNTL117.8%

Asset Turnover (TTM)

ARTV0.00x

ZNTL0.00x

FCF Yield (TTM)

ARTV-22.8%

ZNTL-68.2%

Earnings Yield (TTM)

ARTV-12.5%

ZNTL-32.9%

Dividend Yield (TTM)

ARTVN/A

ZNTLN/A

Rule of 40

ARTV0.0

ZNTL0.0

EV/GP/RG

ARTVN/A

ZNTLN/A

Ticker research

View ARTV research View ZNTL research

Metric	ARTV Artiva Biotherapeutics Inc	ZNTL Zentalis Pharmaceuticals Inc
Market & Valuation
Market Cap	$337M	$188M
Enterprise Value	$36M	$163M
Price	$6.94	$2.64
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	1.70x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-1.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	447.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-42M	$-62M
FCF (TTM)	$-77M	$-128M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-6022.0%	-5277.0%
ROA (TTM)	-5238.0%	-4055.0%
ROIC (TTM)	-6019.0%	-5277.0%
Financial Health
Cash	$301M	$25M
Debt	$0	$0
Net Cash/Debt	$301M	$25M
Current Ratio (TTM)	24.16x	4.82x
Quick Ratio (TTM)	23.97x	4.64x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.92
52W Performance	131.3%	61.0%
YTD Performance	64.1%	92.7%
% from 52W High	-52.2%	-62.0%
% from 52W Low	156.1%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-22.8%	-68.2%
Earnings Yield (TTM)	-12.5%	-32.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View ZNTL research

Valuation

P/S Ratio

ARTV

0.00x

ZNTL

0.00x

EV/FCF

ZNTL

-1.27x

ARTV

-0.46x

Growth & revenue

Forward Revenue Growth

ZNTL

447.5%

ARTV

404.4%

Profitability & performance

Gross Margin

ARTV

0.0%

ZNTL

0.0%

ROE

ZNTL

-5277.0%

ARTV

-6022.0%

FCF Yield %

ARTV

-22.8%

ZNTL

-68.2%

52-Week Performance

ARTV

131.3%

ZNTL

61.0%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

ZNTL

Zentalis Pharmaceuticals Inc

Market Cap

ARTV$337M

ZNTL$188M

Enterprise Value

ARTV$36M

ZNTL$163M

Price

ARTV$6.94

ZNTL$2.64

P/E Ratio

ARTVN/A

ZNTLN/A

P/S Ratio

ARTV0.00x

ZNTL0.00x

EV/Sales

ARTV0.00x

ZNTL0.00x

EV/EBITDA

ARTV0.00x

ZNTL0.00x

P/B Ratio

ARTV0.96x

ZNTL1.70x

P/FCF Ratio

ARTVN/A

ZNTLN/A

EV/FCF

ARTV-0.46x

ZNTL-1.27x

PEG Ratio

ARTVN/A

ZNTLN/A

Forward P/E (NTM)

ARTVN/A

ZNTLN/A

Forward P/S (NTM)

ARTVN/A

ZNTLN/A

Revenue (TTM)

ARTV$0

ZNTL$0

Revenue Growth (YoY)

ARTVN/A

ZNTLN/A

Forward Rev Growth

ARTV404.4%

ZNTL447.5%

Gross Margin (TTM)

ARTV0.0%

ZNTL0.0%

Operating Margin (TTM)

ARTV0.0%

ZNTL0.0%

EBITDA Margin (TTM)

ARTV0.0%

ZNTL0.0%

Net Margin (TTM)

ARTV0.0%

ZNTL0.0%

FCF Margin (TTM)

ARTVN/A

ZNTLN/A

Net Income (TTM)

ARTV$-42M

ZNTL$-62M

FCF (TTM)

ARTV$-77M

ZNTL$-128M

EPS (TTM)

ARTV$0.00

ZNTL$0.00

ROE (TTM)

ARTV-6022.0%

ZNTL-5277.0%

ROA (TTM)

ARTV-5238.0%

ZNTL-4055.0%

ROIC (TTM)

ARTV-6019.0%

ZNTL-5277.0%

Cash

ARTV$301M

ZNTL$25M

Debt

ARTV$0

ZNTL$0

Net Cash/Debt

ARTV$301M

ZNTL$25M

Current Ratio (TTM)

ARTV24.16x

ZNTL4.82x

Quick Ratio (TTM)

ARTV23.97x

ZNTL4.64x

Debt/Equity (TTM)

ARTV0.00x

ZNTL0.00x

Debt/Assets (TTM)

ARTV0.0%

ZNTL0.0%

Interest Coverage (TTM)

ARTVN/A

ZNTLN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

ZNTL0.00x

Beta

ARTV5.80

ZNTL1.92

52W Performance

ARTV131.3%

ZNTL61.0%

YTD Performance

ARTV64.1%

ZNTL92.7%

% from 52W High

ARTV-52.2%

ZNTL-62.0%

% from 52W Low

ARTV156.1%

ZNTL117.8%

Asset Turnover (TTM)

ARTV0.00x

ZNTL0.00x

FCF Yield (TTM)

ARTV-22.8%

ZNTL-68.2%

Earnings Yield (TTM)

ARTV-12.5%

ZNTL-32.9%

Dividend Yield (TTM)

ARTVN/A

ZNTLN/A

Rule of 40

ARTV0.0

ZNTL0.0

EV/GP/RG

ARTVN/A

ZNTLN/A

Ticker research

View ARTV research View ZNTL research

Metric	ARTV Artiva Biotherapeutics Inc	ZNTL Zentalis Pharmaceuticals Inc
Market & Valuation
Market Cap	$337M	$188M
Enterprise Value	$36M	$163M
Price	$6.94	$2.64
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	1.70x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-1.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	404.4%	447.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-42M	$-62M
FCF (TTM)	$-77M	$-128M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-6022.0%	-5277.0%
ROA (TTM)	-5238.0%	-4055.0%
ROIC (TTM)	-6019.0%	-5277.0%
Financial Health
Cash	$301M	$25M
Debt	$0	$0
Net Cash/Debt	$301M	$25M
Current Ratio (TTM)	24.16x	4.82x
Quick Ratio (TTM)	23.97x	4.64x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	1.92
52W Performance	131.3%	61.0%
YTD Performance	64.1%	92.7%
% from 52W High	-52.2%	-62.0%
% from 52W Low	156.1%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-22.8%	-68.2%
Earnings Yield (TTM)	-12.5%	-32.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View ZNTL research